New proton therapy trial aims to spare immune system in cervical cancer

NCT ID NCT07298642

Recruiting now Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares proton therapy to standard photon radiation for cervical cancer patients who need extended-field radiation. The goal is to see if proton therapy causes less severe lymphopenia (low white blood cell count) and fewer side effects. About 44 participants with advanced cervical cancer will be enrolled, and researchers will monitor immune cells and treatment toxicities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Proton radiation therapy
What this could lead to: If successful, this could show that proton therapy is a better option for cervical cancer patients needing extended-field radiation, potentially reducing side effects and improving survival.
What could go wrong: This is a mid-stage trial with only 44 participants, so results may not apply to everyone. Proton therapy is not widely available and may not prove significantly better than standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER

Contacts and locations

Locations

Chang Gung Memorial Hospital
RECRUITING

Taoyuan, Taiwan
National Taiwan University Hospital
RECRUITING

Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.